SCHEMBL469068

SCHEMBL469068

NC(C=O)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5686558 1.00
SCHEMBL8536 1.00
Hydrochloric Acid SCHEMBL30708964 0.97 SLC22A6 (0.39)
Hydrochloric Acid SCHEMBL29274064 0.97 SLC22A6 (0.39)
SCHEMBL29045971 0.97
SCHEMBL7397717 0.78
SCHEMBL8991588 0.78
SCHEMBL10519890 0.78
SCHEMBL17234507 0.76
SCHEMBL7416325 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103896923-B A kind of Hypoglycemics, its preparation method, comprise its medical composition and its use BEIJING LAIDESAILUSEN PHARMACEUTICAL S. & T. INC. (CN) 2016-03-02 CN claimed
CN-103896923-A Blood sugar reducing compound, preparation method of blood sugar reducing compound, medicine composition including blood sugar reducing compound and application of medicine composition BEIJING LABSOLUTIONS PHARMACEUTICALS CO LTD 2014-07-02 CN claimed
US-20250369024-A1 Acyloin Condensation Reactions, Enzymes, and Products Thereof MOJIA BIOTECH PTE LTD (SG) 2025-12-04 US disclosed
EP-4649157-A2 ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF Mojia Biotech Pte. Ltd. (SG) 2025-11-19 EP disclosed
WO-2025090774-A1 CHEMOTHERAPEUTIC COMPOUNDS AND METHODS OF USE SEAGEN INC. (US) 2025-05-01 WO disclosed
US-12226393-B2 Neuroprotective compounds for amyotrophic lateral sclerosis THE JOHNS HOPKINS UNIVERSITY (US) 2025-02-18 US disclosed
WO-2024150067-A2 ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF MOJIA BIOTECH PTE. LTD. (SG) 2024-07-18 WO disclosed
US-20240229047-A1 CARBOXYLIC ACID PLATFORM FOR FUEL AND CHEMICAL PRODUCTION AT HIGH CARBON AND ENERGY EFFICIENCY MOJIA BIOTECH PTE LTD (SG) 2024-07-11 US disclosed
CN-118251496-A Carboxylic acid platforms for high carbon and energy efficient fuel and chemical production 摩珈生物科技有限公司 2024-06-25 CN disclosed
WO-2024096564-A1 ANTIBODY-DRUG CONJUGATE COMPRISING ANTI-CLAUDIN-18.2 ANTIBODY, AND THERAPEUTIC USE THEREOF FOR CANCER 앱티스 주식회사 2024-05-10 WO disclosed
WO-2024081619-A1 CHELATING COMPOSITIONS AND METHODS OF USE LOCUS SOLUTIONS IPCO, LLC (US) 2024-04-18 WO disclosed
EP-0784628-A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME Vertex Pharmaceuticals Incorporated (US) 1997-07-23 EP disclosed
WO-1996030395-A2 CYSTEINE PROTEASE INHIBITOR TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-10-03 WO disclosed
WO-1995035308-A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 1995-12-28 WO disclosed
US-5463118-A Stable in acidic aqueous solutions TAKASAGO INTERNATIONAL CORPORATION (JP) 1995-10-31 US disclosed
EP-0648128-A4 DNA ENCODING PRECURSOR INTERLEUKIN 1-g(b) CONVERTING ENZYME. MERCK & CO INC (US) 1995-07-26 EP disclosed
EP-0648128-A1 DNA ENCODING PRECURSOR INTERLEUKIN 1$g(b) CONVERTING ENZYME MERCK & CO. INC. (US) 1995-04-19 EP disclosed
WO-1994015924-A1 CHOLECYSTOKININ ANTAGONISTS MERCK & CO., INC. (US) 1994-07-21 WO disclosed
WO-1994000154-A1 DNA ENCODING PRECURSOR INTERLEUKIN 1β CONVERTING ENZYME MERCK & CO., INC. (US) 1994-01-06 WO disclosed
EP-0046711-B1 FLUORINATED AMINO-BUTYRIC ACID AND DIAMINOBUTANE DERIVATIVES MERRELL TORAUDE ET COMPAGNIE (FR) 1984-09-05 EP disclosed